pharmaphorum

APRIL 25, 2022

Gani started BehaVR in 2016 to create DTx for mental and behavioural health. He says after a meeting between him and a leader at Sumitomo in 2018 or 2019, it became apparent both companies believed in the power of VR in mental health care. Configuring a collaboration. “This area is a constant learning lesson.

Behavioural Health 105

Behavioural Health Production Clinical Trials Clinical Trials 105

pharmaphorum

OCTOBER 2, 2020

Modia is designed to close the gap as it relates to the access and receipt of quality, evidence-based therapeutic interventions and behavioural health services for individuals with OUD who participate in outpatient treatment with MAT,” said Michael Sumner, Orexo’s chief medical officer.

Behavioural Health 98

Behavioural Health Production FDA Approval Pharma Production 98

pharmaphorum

APRIL 6, 2021

The FDA’s approval under the de novo classification framework for medical devices that are likely to be safe and effective for their intended use, but for which there are no similar devices already available on the market. The approval means the Oxford University spin-out can place Oxevision on the market in all US states.

Nurses 59

Nurses Behavioural Health FDA Approval Clinical Trials 59

pharmaphorum

JANUARY 27, 2022

Immersive technology can also help improve assessments of the effectiveness of treatment, particularly regarding behavioural health where a patient’s results are often subjective. For example, mental health disorders and cognitive decline are rising.

Production 142

Production Development Behavioural Health Research 142

pharmaphorum

JANUARY 26, 2021

There is an opportunity to address this at scale with digital tools and techniques, and expand support into just about any therapeutic area through the holistic integration of mental and behavioural health solutions that improve patient care. Consolidation of digital health platforms.

Clinical Trials 141

Clinical Trials Clinical Trials Sales Life Science 141

pharmaphorum

JANUARY 5, 2023

“We believe having access to patient-reported data via Pear’s clinician dashboard gives us better insight into patient behaviours.”. Pear is also working with other addiction specialists, including Florida-based Cove Behavioural Health, and provides its DTx to a number of state health programmes.

Behavioural Health 52

Behavioural Health FDA Approval Licensing Licensing 52

pharmaphorum

DECEMBER 16, 2022

Digital therapeutics company Cognoa, which focuses on paediatric behavioural health, announced the appointment of Dr Sharief Taraman as its new CEO. A number of pharma-adjacent tech firms and non-profits announced personnel news in the month of November. We’ve rounded up some highlights below. Digital therapeutics hires.

Behavioural Health 52

Behavioural Health Reagent Gene Therapy Production 52